Volume 3 Issue 3
Full PDF: http://www.mcs-america.org/March2008.pdf
Article Previews on the Web with Links to Individual Articles:
Multiple Chemical Sensitivity Beleaguered, Part 2
Last month a basic overview of the industry disinformation campaign against multiple chemical sensitivity was presented. This month continues to explore this issues in more depth. As a fitting start to this months exploration, Mary Ebeling's Beyond Advertising: The Pharmaceutical Industry's Hidden Marketing Tactics was published on February 21st at PR Watch. In her article, Ebeling describes the marketing tactics engaged in by pharmaceutical companies to increase profits, including celebrity endorsements and specific communication targets for direct to consumer drug advertisements aimed at mothers of certain income.
Medication Under a Microscope
Multiple Chemical Sensitivities
Copyrighted © 2008 MCS
This post is for information purposes only. It is not intended to replace the examination, diagnosis, and treatment of a licensed physician and no such claims are inferred. Articles are not necessarily the opinion of MCS America or the poster. There is no financial interest in this post. Posting does not constitute endorsement. Neither MCS America nor the poster will be responsible for misuse of this information. This service is provided free of charge by volunteer efforts.
The mission of MCS America (MCSA) is to gain medical, legal, and social recognition for multiple chemical sensitivity (MCS) as a disorder of organic biological origin induced by toxic environmental insults. Secondarily, MCSA seeks to ensure that environmental toxicants are identified, reduced, regulated, and enforced through lobbying for effective legislation.